These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1256308)

  • 1. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
    Knop P; Kindler U; Merholz T
    Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electroencephalographic changes and antitubercular treatments].
    Piéron R; Gautier H; Duhurt J; Kauffmann JP
    Sem Hop; 1972 Oct; 48(40):2585-91. PubMed ID: 4344846
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug therapy of pulmonary tuberculosis].
    Ludes H
    Dtsch Med Wochenschr; 1972 Feb; 97(8):289-91. PubMed ID: 5058425
    [No Abstract]   [Full Text] [Related]  

  • 5. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 7. [Eosinophilic infiltrations of the lung as a radiologic manifestation of hypersensitivity to streptomycin, PAS and INH].
    Furman Z
    Gruzlica; 1967 Jan; 35(1):65-9. PubMed ID: 6044451
    [No Abstract]   [Full Text] [Related]  

  • 8. [[Comparative studies on therapeutic effects of SM.INH.PAS, SM.INH.PAS.EB twice weekly, and SM.INH.PAS.EB daily in original treatment cases of pulmonary tuberculosis].
    Kekkaku; 1971 Aug; 46(8):325-33. PubMed ID: 4998863
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe hypersensitivity to SM, INH and PAS in a child with post-primary tuberculosis].
    Rykowska Z
    Gruzlica; 1969 Aug; 37(8):777-81. PubMed ID: 4242816
    [No Abstract]   [Full Text] [Related]  

  • 11. [The course of pulmonary tuberculosis in the initial phase of various intensive therapy combinations].
    Kindler U; Derichs R; Merholz S
    Med Welt; 1976 Feb; 27(8):387-8. PubMed ID: 1256307
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tuberculostatics. General adverse effects].
    Mordasini ER; Eulenberger J
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):499-518. PubMed ID: 4339952
    [No Abstract]   [Full Text] [Related]  

  • 14. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. I. Clinical comparison of SM, INH and EB regimen with SM, INH and PAS regimen].
    Makiyama H
    Kekkaku; 1969 Jun; 44(6):181-7. PubMed ID: 5805784
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
    Toyota E; Suzuki T; Tagawa K; Takahara M; Ito M; Arai T; Kabe J; Baba H
    Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New guidelines for pulmonary tuberculosis therapy].
    Steiner A; Medici TC
    Dtsch Med Wochenschr; 1978 Mar; 103(9):372-5. PubMed ID: 631063
    [No Abstract]   [Full Text] [Related]  

  • 19. [Standardized controlled antitubercular therapy and results in 755 patients].
    Wiesner B; Cramer G; Hamel U; Roth G
    Z Erkr Atmungsorgane; 1991; 177(1-2):71-5. PubMed ID: 1808855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A resected case of Mycobacterium szulgai pulmonary disease.
    Tsuyuguchi K; Amitani R; Matsumoto H; Tanaka E; Suzuki K; Yanagihara K; Mizuno H; Hitomi S; Kuze F
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):258-60. PubMed ID: 9526201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.